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Exclusion of host cells during spheroid formation from
disaggregated solid tumours
P.R. Twentyman
MRC Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Hills Road, Cambridge, CB2 2QH.
Multicellular tumour spheroids have become widely
used as a 3-dimensional in vitro model system in
radiobiology and experimental chemotherapy
(Sutherland & Durand, 1976; Yuhas et al., 1977;
Haji-Karim & Carlsson, 1978; Twentyman, 1980).
In general, however, spheroids have been initiated
either from established tumour cell lines or from
cell populations passaged in monolayer in vitro
from solid tumours. There has been much recent
interest in the possibility of growing spheroids
directly from disaggregated clinical tumour
material. Suspensions prepared from solid tumours
generally contain a considerable population of
normal host cells including macrophages,
endothelial cells, lymphocytes and granulocytes
(Siemann et al., 1981). The proportions will vary
between tumour types, but investigation of two
different sublines of the EMT6 mouse tumour have
showed that - 40% of the total cellular
composition consists of macrophages (Stewart &
Beetham, 1978; Siemann et al., 1981). We therefore
decided to investigate whether spheroids derived
from the established EMT6 mouse tumour or from
a human tumour xenograft contain such cells and,
if so, whether their presence has any significance
for therapeutic response.
EMT6/Ca/VJAC is an established mouse tumour
line that will grow either in vitro or as a solid
tumour in BALB/c mice. Tumour cells have a
DNA content approximately twice that of normal
mouse diploid cells as demonstrated using flow
cytometry (Twentyman & Watson, 1977). A
suspension prepared from the solid tumour contains
-40% host cells and these may be separated from
tumour cells by a selective adherence technique
(Twentyman & Watson, 1977). HT29 is a human
colon carcinoma cell line (Von Kleist et al., 1975)
which will grow as a solid tumour xenograft in
immunodeprived mice. In culture HT29 cells also
have approximately twice the DNA content per cell
of normal mouse diploid cells, but a cell suspension
prepared from a tumour xenograft contains
typically 30-40% of diploid cells. It has been
demonstrated using immunocytochemistry that the
stromal content of HT29 xenografts is of mouse
origin (Warenius, 1980).
Cell suspensions were prepared either from
EMT6 mouse tumours or from HT29 xenografts
using trypsin alone or trypsin plus versene
respectively. From the resulting suspensions, 5 x 105
cells in 15ml of medium were placed into 75cm2
tissue culture flasks which had been base-coated
with medium containing 1% Difco Noble Agar to
prevent cell adherence. For EMT6, the medium
used was Eagle's MEM with 20% new born calf
serum. For HT29 Eagle's MEM with 10% foetal
calf serum was used (all from Gibco Biocult).
For EMT6, small aggregates of cells were present
in the medium one day after inoculation and by the
second day, there were many small spheroids
-50,m diameter. Aggregate formation from HT29
took rather longer and 4-5 days transpired before
spheroids of a similar diameter were seen. These
small spheroids then continued to grow at a similar
rate to that found for spheroids initiated from
monolayer cultures of the two lines.
On day 2 (for EMT6) or day 4 (for HT29), the
largest spheroids from the flasks were separated
from single cells and smaller aggregates by being
layered on to the surface of 15 ml medium
contained in a plastic universal tube. When the
spheroids had settled to the bottom, the bulk of the
medium was removed. This procedure was repeated
3 x. Spheroids were then disaggregated using either
trypsin (EMT6) or trypsin plus versene (HT29).
The cell suspensions prepared from the original
solid tumours and from the disaggregated spheroids
were analysed by flow cytometry for DNA content
per nucleus using the rapid ethidium bromide
staining technique (Krishan, 1975).
In one experiment with EMT6, we used our
selective adherence technique to produce
populations enriched in tumour or host components
from an EMT6 tumour. A suspension was then re-
constituted in which the normal proportion of
host/tumour cells was increased by a factor of 8.
DNA distribution diagrams obtained by flow
cytometry for EMT6 suspensions are shown in
Figure I (a-d). It can be seen that from the two
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(a) the tumour cells may be separated from diploid
host cells by selective adherence (b). EMT6
spheroids disaggregated on day 2 are shown in (c)
(grown from the original tumour suspension) and
(d) (from a suspension reconstituted from 8 parts of
floating cells to 1 part adherent cells). It is clear
that in each case there are no diploid cells present
in the spheroids.
DNA distributions of cells from HT29 solid
tumours and spheroids were similar to those from
EMT6 and are shown in Figure 2. Again no diploid
cells were present in suspensions prepared from
spheroids.
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Figure 2 Distribution of DNA content per nucleus
for HT29 cell populations: (a) from disaggregated
solid tumour; (b) from day 4 aggregates of cells from
the solid tumour suspension. Staining techniques and
calibration as for Figure 1.
DNA per nucleus
Figure 1 Distribution of DNA content per nucleus
for EMT6 cell populations: (a) from disaggregated
solid tumour; (b) from tumour cells separated from the
solid tumour suspension by selective adherence; (c)
from day 2 aggregates of cells from the solid tumour
suspension; (d) from day 2 aggregates of cells from the
solid tumour suspension enriched (8X) with non-
adherent cells. The distributions were obtained by flow
cytometry using a rapid staining technique (Krishan,
1975) with ethidium bromide. The first peak in (a)
corresponds to the position of the GI peak of normal
mouse diploid cells as calibrated using normal bone
marrow.
The absence of diploid cells in spheroids grown
from tumour cell suspensions could be due to (a) a
failure of diploid cells to participate in the initial
aggregation process leading to spheroid formation,
(b) death and lysis of diploid cells having
participated in aggregation or (c) their proportional
presence having become undetectably small due to
rapid proliferation of tumour cells compared with
diploid cells. We have no reason to believe that (b)
occurs because, firstly, host cells are clearly able to
co-exist with tumour cells in the solid tumour and,
secondly, we have found that monolayer cultures
initiated from tumour suspensions have intact
diploid cells floating in the medium for several days.
In consideration of the numbers argument (c), it is
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highly unlikely that more than 2-3 divisions of
tumour cells occur in the 2 days leading to the
formation of EMT6 aggregates of 50,um diameter.
Hence, the 40% of host cells present in the
original suspension would be reduced to no less
than 5-10% after 2 days by tumour cell
proliferation alone. It is clear from the DNA
distribution diagrams that such a host cell
component is not present (even when the diploid
population is artifically enriched in the original
suspension). The most likely explanation of the data
is, therefore, that spheroids are formed by the
selective aggregation of tumour cells alone. It is, of
course, likely that the tissue culture conditions
which we have used are unsuitable for the
proliferation of normal tissue elements. This would
not, however, necessarily prevent their
incorporation into tumour spheroids as a non-
dividing stromal component. Such a process does
not appear to occur. With this conclusion it is not
therefore possible to use such a system to examine
whether the presence of host cells influences the
response to therapeutic modalities of tumour cells
in small spheroids.
I thank Mr. S. Chambers for carrying out the flow
cytometric analysis of the cell suspensions.
References
HAJI-KARIM, M. & CARLSSON, J. (1978). Proliferation
and viability in cellular spheroids of human origin.
Cancer Res., 38, 1457.
KRISHAN, A. (1975). Rapid flow cytofluorometric analysis
of mammalian cell cycle by propidium iodide staining.
J. Cell Biol., 66, 188.
SIEMANN, D.W., LORD, E.M., KENG, P.C. & WHEELER,
K.T. (1981). Cell subpopulations dispersed from solid
tumours and separated by centrifugal elutriation. Br.
J. Cancer, 44, 100.
STEWART, C.C. & BEETHAM, P.L. (1978). Cytocidal
activity and proliferation ability of macrophages
infiltrating the EMT6 tumor. Int. J. Cancer, 22, 152.
SUTHERLAND, R.M. & DURAND, R.E. (1976). Radiation
response of multicell spheroids: An in vitro tumour
model. Curr. Top. Radiat. Res. Q., 11, 87.
TWENTYMAN, P.R. (1980). Response to chemotherapy of
EMT6 spheroids as measured by growth delay and cell
survival. Br. J. Cancer, 42, 297.
TWENTYMAN, P.R. & WATSON, J.V. (1977). Separation of
clonogenic tumour cells from EMT6 mouse mammary
tumours. Br. J. Cancer, 35, 120.
VON KLEIST, S., CHANG, E., BARTIN, P., KING, M. &
FOGH, J. (1975). Immunohistology of the antigenic
pattern of a continuous cell line from a human colon
tumour. J. Natl Cancer Inst., 55, 555.
WARENIUS, H.M. (1980). Identification and separation of
mouse and human components of heterotransplanted
human tumours. In: Immunodeficient Animals for
Cancer Research. (Ed. Sparrow), London: Macmillan,
p. 207.
YUHAS, J.M., LI, A.P., MARTINEZ, A.O. & LADMAN, A.J.
(1977). A simplified method for production and
growth of multicellular tumour spheroids. Cancer Res.,
37, 3639.